Search research articles
Contact Us
Filters
Showing results (41-50 of 135) with videos related to
Page
of 14
Sort By:
Journal of Neurovirology
|
September 13, 2006
Positron emission tomography imaging of peripheral benzodiazepine receptor binding in human immunodeficiency virus-infected subjects with and without cognitive impairment
Clayton A Wiley, Brian J Lopresti, James T Becker, et al.
Molecular Imaging and Biology
|
March 3, 2011
Human biodistribution and dosimetry of the PET radioligand [¹¹C]flumazenil (FMZ)
Charles M Laymon, Rajesh Narendran, Neale S Mason, et al.
Synapse (New York, N.Y.)
|
May 17, 2001
Analyses of [(18)F]altanserin bolus injection PET data. II: consideration of radiolabeled metabolites in humans
J C Price, B J Lopresti, C C Meltzer, et al.
Alzheimer'S Research & Therapy
|
May 11, 2021
Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach
Sarah K Royse, Davneet S Minhas, Brian J Lopresti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 18, 2009
Human biodistribution and dosimetry of the D2/3 agonist 11C-N-propylnorapomorphine (11C-NPA) determined from PET
Charles M Laymon, N Scott Mason, W Gordon Frankle, et al.
Molecular Psychiatry
|
February 27, 2013
Imaging dopamine transmission in the frontal cortex: a simultaneous microdialysis and [11C]FLB 457 PET study
R Narendran, H P Jedema, B J Lopresti, et al.
Journal of Alzheimer'S Disease : JAD
|
April 12, 2021
An Effect of Education on Memory-Encoding Activation in Subjective Cognitive Decline
Akiko Mizuno, Helmet T Karim, Maria J Ly, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 28, 2010
A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatum
Rajesh Narendran, N Scott Mason, Charles M Laymon, et al.
The American Journal of Psychiatry
|
December 24, 2011
In vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusers
Rajesh Narendran, Brian J Lopresti, Diana Martinez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Alzheimer's Imaging Consortium
Laura Alejandra Ramirez Tirado, Ann D Cohen, C Elizabeth Shaaban, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 135) with videos related to
Sort By:
Page
of 14
Journal of Neurovirology
|
September 13, 2006
Positron emission tomography imaging of peripheral benzodiazepine receptor binding in human immunodeficiency virus-infected subjects with and without cognitive impairment
Clayton A Wiley, Brian J Lopresti, James T Becker, et al.
Molecular Imaging and Biology
|
March 3, 2011
Human biodistribution and dosimetry of the PET radioligand [¹¹C]flumazenil (FMZ)
Charles M Laymon, Rajesh Narendran, Neale S Mason, et al.
Synapse (New York, N.Y.)
|
May 17, 2001
Analyses of [(18)F]altanserin bolus injection PET data. II: consideration of radiolabeled metabolites in humans
J C Price, B J Lopresti, C C Meltzer, et al.
Alzheimer'S Research & Therapy
|
May 11, 2021
Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach
Sarah K Royse, Davneet S Minhas, Brian J Lopresti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 18, 2009
Human biodistribution and dosimetry of the D2/3 agonist 11C-N-propylnorapomorphine (11C-NPA) determined from PET
Charles M Laymon, N Scott Mason, W Gordon Frankle, et al.
Molecular Psychiatry
|
February 27, 2013
Imaging dopamine transmission in the frontal cortex: a simultaneous microdialysis and [11C]FLB 457 PET study
R Narendran, H P Jedema, B J Lopresti, et al.
Journal of Alzheimer'S Disease : JAD
|
April 12, 2021
An Effect of Education on Memory-Encoding Activation in Subjective Cognitive Decline
Akiko Mizuno, Helmet T Karim, Maria J Ly, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 28, 2010
A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatum
Rajesh Narendran, N Scott Mason, Charles M Laymon, et al.
The American Journal of Psychiatry
|
December 24, 2011
In vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusers
Rajesh Narendran, Brian J Lopresti, Diana Martinez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Alzheimer's Imaging Consortium
Laura Alejandra Ramirez Tirado, Ann D Cohen, C Elizabeth Shaaban, et al.
Page
of 14